Each one in plain English, with the numbers worked through for a shareholder.
12 July 2016capital raising announcement▲ GoodMajor
Elixir plans to raise about $2.2m: a placement of $234,038 now plus $205,962 subject to approval, then a 1:1 rights issue for about $1.8m after a 25-to-1 share consolidation. About 179 million shares would be on issue afterwards. Funds support existing assets and new ventures.
Share purchase plan closed early, fully subscribed at 303,983,507 shares ($303,983) at $0.001. Cliff Head due diligence shows no unexpected technical issues, but key commercial and legal matters remain open. Funds go to the acquisition, or otherwise working capital and new deals.
Share purchase plan offer to shareholders at $0.001 per share, the same price as the placement, in parcels of $2,500 to $15,000. It opens 2 November and closes 23 November 2015, with a maximum of about 310m shares. Details of the raising announced earlier.
28 Oct 2015capital raising announcement● NeutralMajor
Elixir raised $258,320 via a placement of 258m shares, and offers a share purchase plan of up to $309,984, for up to $618,304 in total including a possible $50,000 from directors. Funds mainly go to the Cliff Head deal. Small relative to the $3m funding condition.
What it means for a shareholder
258m new shares at about A$0.001 to raise about A$258,320. That's 20% dilution: every existing holder's slice gets 20% smaller. If you held A$1,000 of shares (998,761 at the issue price), your slice goes from 0.0967% to 0.0773% of the company. To keep it you'd need 249,381 more shares - about A$250 at the issue price.
4 Aug 2014capital raising announcement● NeutralMajor
Prospectus for the share purchase plan: up to 160m shares at $0.005 (up to $800k), with one free $0.015 option per two shares, plus up to 220m options to placement participants. It needs shareholder approval on 1 September 2014 and closes 29 August.
What it means for a shareholder
160m new shares at A$0.005 to raise about A$800,000. That's 27% dilution: every existing holder's slice gets 27% smaller. If you held A$1,000 of shares (200,000 at the issue price), your slice goes from 0.0464% to 0.0338% of the company. To keep it you'd need 74,198 more shares - about A$371 at the issue price.
13 Aug 2013capital raising announcement● NeutralMajor
Shortfall placed, completing the roughly $1.85m raising at $0.012. Shares on issue rise from about 277m to 431,278,356, a roughly 55% increase. Funds are for Moselle progress.
New Standard bought 83.66m Elixir shares for $1m at 1.2 cents, lifting its stake from 13.7% to 28.2%. It keeps the right to nominate an Elixir director.
Rights issue closed with valid applications for $942,810, about 51% of shares offered. The remaining 75.5m shares (about $906k) go to the underwriter to place, so the raising is fully covered but shareholder take-up was only about half.
Letter to eligible shareholders restating the rights issue: $0.012 a share, five for nine, about $1.85m, underwritten by Argonaut for fees of about $62k. Funds go to Moselle, possible US asset costs and working capital. Nothing new.
Prospectus for the rights issue: up to 154,028,131 shares at $0.012, five for every nine held, closing 1 August 2013. Repeats terms already announced on 5 July.
What it means for a shareholder
154m new shares at A$0.012 to raise about A$1.8m. That's 36% dilution: every existing holder's slice gets 36% smaller. If you held A$1,000 of shares (83,333 at the issue price), your slice goes from 0.0301% to 0.0193% of the company. To keep it you'd need 46,296 more shares - about A$556 at the issue price.
New Standard Energy says it will lift its Elixir stake from 13.7% to between 19.99% and 28.2%, investing up to about $1m at 1.2 cents. It also gains the right to nominate an Elixir director. Same raising as the Elixir announcement.
5 July 2013capital raising announcement● NeutralMajor
Elixir launches a fully underwritten rights issue at $0.012 a share, 5 new for every 9 held, to raise about $1.85m (154m shares). Underwriter is Argonaut; New Standard sub-underwrites $750k and may reach up to 28.2%, with a top-up to 19.99%.
What it means for a shareholder
154m new shares at about A$0.012 to raise about A$1.9m. That's 36% dilution: every existing holder's slice gets 36% smaller. If you held A$1,000 of shares (83,243 at the issue price), your slice goes from 0.03% to 0.0193% of the company. To keep it you'd need 46,238 more shares - about A$555 at the issue price.
The entitlement issue closed with 392 valid applications for 24.2m shares ($1.21m). New Standard, as underwriter, takes the 9.93m-share shortfall ($496,420). Together with the placement, the raising totals about $2.1m from the entitlement and placement.
What it means for a shareholder
24.2m new shares at about A$0.0868 to raise about A$2.1m. That's 10% dilution: every existing holder's slice gets 10% smaller. If you held A$1,000 of shares (11,524 at the issue price), your slice goes from 0.0053% to 0.00477% of the company. To keep it you'd need 1,283 more shares - about A$111 at the issue price.
The 6.4m-share placement to New Standard at $0.0625 was completed, raising $400,000 without shareholder approval. Issued shares rise to 223.7m. Completes the first part of the March raising.
Cleansing notice and offer document for the 1-for-6 entitlement issue at $0.05 (up to ~36.2m shares), fully underwritten by New Standard; offer opens 16 March and closes 30 March. Administrative step of the announced raising.
Shareholder letter restates the 1-for-6 entitlement issue at $0.05 (up to 36.2m shares, closing 30 March). Funds are for Moselle well planning and farmout, new asset opportunities and working capital. No new terms.
Elixir will raise about $2.2m: a $400,000 placement of 6.4m shares to New Standard at $0.0625, plus a 1-for-6 entitlement issue at $0.05 (up to ~$1.81m), fully underwritten by New Standard for no fee. Follows the earlier flagged capital raising options.
What it means for a shareholder
6.4m new shares at A$0.0625 to raise about A$400,000. That's 2.9% dilution: every existing holder's slice gets 2.9% smaller. If you held A$1,000 of shares (16,000 at the issue price), your slice goes from 0.00736% to 0.00715% of the company. To keep it you'd need 471 more shares - about A$29 at the issue price.
New Standard Energy (ASX:NSE) plans to take up to a 15% stake in Elixir for up to about $2.25m, via a placement at 6.25 cents plus underwriting of Elixir's 5 cent entitlement issue. It is a strategic investor in Moselle.
5 Oct 2011capital raising announcement● NeutralMajor
Elixir is raising up to A$1.132m through 28.3m shares at $0.04, with largest shareholder Aurora taking part, to fund Moselle well planning. Issued shares rise to 217.3m. Alan Watson joins the board and is expected to replace Jon Stewart as chair at the November AGM.
What it means for a shareholder
28.3m new shares at A$0.040 to raise about A$1.1m. That's 13% dilution: every existing holder's slice gets 13% smaller. If you held A$1,000 of shares (25,000 at the issue price), your slice goes from 0.0132% to 0.0115% of the company. To keep it you'd need 3,744 more shares - about A$150 at the issue price.
Elixir completed allotment of 5,920,000 shortfall shares at 27c to professional investors, the placement announced on 2 July. Administrative completion of the entitlement shortfall.
Entitlement issue take-up was only about 9.7% (1.95m shares, A$527k). The underwriter terminated after a market fall, but directors placed ~5.9m shortfall shares at 27c (A$1.6m). Elixir says cash is about A$12m.
Elixir says the entitlement offer document was mailed to eligible shareholders on 12 June; the offer closes 27 June. Administrative notice with no new substance.
Elixir lodges the compliance notice and offer document for its 1-for-8 entitlement issue at 27c, up to 20.1m shares. The offer closes 27 June and is underwritten by Stripe Capital. Details were already announced on 29 May.
Elixir finalised the first placement of 20m shares at 27c, raising A$5.4m, below the 24.15m shares announced on 29 May. A further 13.5m shares are planned for European clients, with 9.35m needing shareholder approval at a 7 July meeting.
What it means for a shareholder
20.0m new shares at A$0.270 to raise about A$5.4m. That's 11% dilution: every existing holder's slice gets 11% smaller. If you held A$1,000 of shares (3,704 at the issue price), your slice goes from 0.0023% to 0.00204% of the company. To keep it you'd need 460 more shares - about A$124 at the issue price.
29 May 2008capital raising announcement● NeutralMajor
Elixir launches a raising of up to 53.64m shares at 27c to raise up to A$14.5m: placements plus a 1-for-8 underwritten entitlement issue. Funds go to more Pompano wells, Sierra Leone and North Sea work. Price is a 12.3% discount to the 5-day average. Blue Oar appointed AIM adviser.
What it means for a shareholder
53.6m new shares at A$0.270 to raise about A$14.5m. That's 25% dilution: every existing holder's slice gets 25% smaller. If you held A$1,000 of shares (3,704 at the issue price), your slice goes from 0.0023% to 0.00172% of the company. To keep it you'd need 1,233 more shares - about A$333 at the issue price.
25 Jan 2008capital raising announcement● NeutralMajor
Elixir will issue 8,571,429 unsecured convertible notes at $0.35 to Macquarie Bank, raising $3.0m for Pompano drilling and working capital. Notes convert at $0.35 to 31 Dec 2008, otherwise redeem 31 Jan 2009; interest is 10% a year.
9 July 2007capital raising announcement● NeutralMajor
Elixir proposed issuing 10.7m convertible notes at A$0.25, raising about A$2.7m, to fund Gawler's Gulf of Mexico development. The notes carry an 8% coupon and convert into Elixir shares at A$0.25 or are redeemable in November 2008. Underwritten by Argonaut.
1 June 2006capital raising announcement● NeutralMajor
Elixir is placing 6.5 million shares at 40 cents each to sophisticated investors, raising A$2.6m, managed by Argonaut Securities. Funds are for opportunities in the existing portfolio and adding new ones.
What it means for a shareholder
6.5m new shares at A$0.400 to raise about A$2.6m. Shares on issue before the raise aren't in the record, so the dilution can't be worked out.